The BrainMap database is a community resource that curates peer-reviewed, coordinate-based human neuroimaging literature. By pairing the results of neuroimaging studies with their relevant meta-data, BrainMap facilitates coordinate-based meta-analysis (CBMA) of the neuroimaging literature en masse or at the level of experimental paradigm, clinical disease, or anatomic location.
(SPECT). Here, a separate sector of BrainMap is introduced for structural MRI studies that employ voxel-based morphometry (VBM), titled:
BrainMap VBM. VBM is a mass-univariate, whole-brain analysis of local grey-or white-matter tissue volume across or within subject groups, where locations of statistical significance are most often reported as xy-z coordinates (cluster center-of-mass or peak voxel) in a standardized coordinate space (Talairach or MNI) (Ashburner & Friston, 2000) . To date, VBM has amassed an extensive literature (4,237 publications in PubMed) that can become more scientifically accessible with the resource we present here. In this work, we comprehensively describe BrainMap VBM's novel design, current data volume, quality assurance strategies, and multi-purpose utility (e.g., region-to-disease inference).
The unique capacity of this new community resource is then illustrated by employing independent components analysis (ICA)-an exploratory, multivariate strategy that has not previously been applied to VBM coordinates.
Coordinate-based meta-analysis (CBMA) has considerably evolved over three decades to provide a powerful family of methods for mining and synthesizing the human neuroscience imaging literature (for review, see Fox, Lancaster, Laird, & Eickhoff, 2014) . BrainMap offers a software suite of cross-platform Java applications for data entry (Scribe), filtered data retrieval (Sleuth) and statistical analysis (GingerALE) (Fox & Lancaster, 2002; Fox et al., 2014) . The most common BrainMap application is assessing the convergence of results in conceptually related experiments that evaluate brain function at the level of task paradigm (e.g., Stroop tasks) or that use task-based activations to contrast clinical patients with healthy controls (e.g., Alzheimer's disease vs. healthy controls assessed using the Stroop task).
Numerous univariate methods exist for this purpose, including activation likelihood estimation (ALE; performed with GingerALE software), multi-level kernel density analysis (MKDA) and signed differential mapping (SDM) Radua & Mataix-Cols, 2012; Turkeltaub, Eden, Jones, & Zeffiro, 2002; Wager, Lindquist, Nichols, Kober, & Van Snellenberg, 2009 ). Each methodology is similar but conceptually distinct, and data compilation/analysis is assisted with (while not explicitly requiring) BrainMap's database structure. Even though these univariate tools were developed for use in the functional literature, multiple studies have demonstrated their clear applicability with structural MRI studies; ALE, for example, has been redefined as "anatomical likelihood estimation" in this context (Barron, Fox, Laird, Robinson, & Fox, 2013; Fornito, Y€ ucel, Patti, Wood, & Pantelis, 2009; Glahn et al., 2008) . ALE, MKDA, and SDM each address a salient topic in the current neuroimaging environment: reproducibility (Mueller, Lepsien, M€ oller, & Lohmann, 2017; Poldrack et al., 2017; Roiser et al., 2016) . In a highly publicized study, Eklund, Nichols, and Knutsson (2016) demonstrated inflated false-positive rates in massive null-fMRI datasets due to faulty cluster-based thresholding by popular software packages. They concluded that cluster-based inference is more sensitive to statistical assumptions (e.g., "uniform smoothness," where local variations in image smoothness are not accounted for) which is corroborated by several VBM studies (Salmond et al., 2002; Scarpazza, Sartori, De Simone, & Mechelli, 2013; Scarpazza, Tognin, Frisciata, Sartori, & Mechelli, 2015; Silver, Montana, & Nichols, 2011) . Silver et al. (2011) also reported inflated false-positives in a VBM null-dataset when applying lower cluster-forming thresholds (a c 5 0.01, 0.05) and smaller smoothing kernels (6 mm). Sample size also contributes to varying VBM results, as larger sample sizes introduce more power and higher sensitivity which reduces type-II error. Fusar Poli et al. (2014) analyzed 324 VBM studies and indeed found a positive, but weak relationship between number of foci reported and sample size. They suggested that reporting biases are more prevalent in smaller studies, which would account for their result. Along with the revaluation of cluster-based statistical methodology, Eklund et al. (2016) recognized that "metaanalysis can play an important role in teasing apart false-positive findings from consistent results."
Meta-analytic connectivity has also been examined with the BrainMap functional database through a variety of multivariate approaches.
Such applications include meta-analytic connectivity modeling (MACM), which identifies the co-activation pattern of an a priori region of interest (ROI; or set of a priori ROIs) by referencing BrainMap's diverse task-activation collection (Robinson, Laird, Glahn, Lovallo, & Fox, 2010 ). An extension of this principle has been used for connectivity-based parcellation (CBP) (Eickhoff, Thirion, Varoquaux, & Bzdok, 2015) , where one ROI is clustered into subregions of discrete functional anatomy based on co-activation networks. Some CBP investigations with BrainMap include the amygdala (Bzdok et al., 2013 ) and the thalamic pulvinar (Barron, Eickhoff, Clos, & Fox, 2015) , which were validated cytoarchitectonically. An unexpected dividend of BrainMap's content and meta-data structure has been considering the functional database en masse (i.e., with sparse filtrations in analysis regarding predefined experimental categories or spatially confined ROIs). Using graph theory, Crossley et al. (2013) compared the frequency at which each pair of 638 ROIs across the whole-brain was co-activated by multiple tasks in BrainMap and found occipital, central, and default-mode modules that were behaviorally specialized as well as rich clubs that were diversely co-activated by tasks requiring both action and cognition (van den Heuvel & Sporns, 2011) . In a particularly innovative strategy, ICA was extended to the functional sector of the BrainMap database by Smith et al. (2009) . Treating each smoothed coordinate (modeled activation; MA) image per experiment as an effective "timepoint" in arbitrary order, they established 10 canonical networks that showed correspondence both during task and resting-state, and attributed behavioral characteristics to each using BrainMap meta-data. We expect many of these analytic strategies to translate to BrainMap VBM. Some initial, large-scale investigations of BrainMap VBM include ALE across six psychiatric disorders (Goodkind et al., 2015) and ALE across more than 25 brain disorders (Crossley et al., 2014) .
Structural covariance (SCov), an analog to functional covariance, is a field of research that BrainMap VBM can offer an equivalent potential of meta-analytic insight. SCov is defined as inter-individual differences in a regional brain structure (cortical thickness or grey matter density) covarying with inter-individual differences in other brain regions (Alexander-Bloch, Giedd, & Bullmore, 2013) . Accumulating research demonstrates that lifespan changes to brain structures do not occur independently but follow multi-regional, coherent patterns that show unique chronological trajectories of integrity and organization (Alexander-Bloch et al., 2013; Li, Pu, Fan, Niu, Li, & Li, 2013; V a sa et al., 2017; Zhu et al., 2012; Zielinski, Gennatas, Zhou, & Seeley, 2010) . SCov has proven to be a sensitive method in studying disease, and alterations exist in a range of disorders that are neurodegenerative (Coppen, van der Grond, Hafkemeijer, Rombouts, & Roos, 2016; Minkova et al., 2016) , psychiatric (Palaniyappan et al., 2015; Wu et al., 2017; Xu, Groth, Pearlson, Schretlen, & Calhoun, 2009) , developmental (Bethlehem, Romero-Garcia, Mak, Bullmore, & Baron-Cohen, 2017; Dziobek, Bahnemann, Convit, & Heekeren, 2010) , systemic (e.g., cardiovascular risk factors) (Kharabian Masouleh et al., 2017) , and even chemotherapy-related (i.e., cognitive impairment) (Hosseini, Koovakkattu, & Kesler, 2012) . A seed-to-whole-brain and seed-to-target transdiagnostic SCov application using BrainMap VBM was recently published by Kotkowski, Price, Mickle Fox, Vanasse, and Fox (2018) .
As the primary motivation for this work is exhibiting the contents and utility of BrainMap VBM, we chose independent components analysis (ICA) as well-suited toward this end. ICA is a whole-brain, voxelwise network analysis technique that decomposes spatial maps according to maximal statistical independence (Beckmann & Smith, 2004) .
Unlike general linear modeling (GLM) and similar methodologies, ICA doesn't require a user-specified reference function (Mckeown et al., 1998) . Here, ICA's exploratory nature is fully leveraged with BrainMap VBM in that many diseases (43) showing grey matter morphology are processed together in a pseudo time-series for pattern identification.
ICA has shown success in identifying SCov components from T1, intersubject covariance data in healthy and diseased populations (Coppen et al., 2016; Eckert, 2010; Hafkemeijer et al., 2014; Kharabian Masouleh et al., 2017; Segall et al., 2012; Xu et al., 2009) . In this study, we demonstrate that ICA of BrainMap VBM coordinates-blind to any diagnostic information-can extract spatially independent components of inter-experiment SCov. In addition, these components comprehensively inform disease specificity through reverse inference (i.e., regionto-disease) methodology presented here. While ICA of functional, meta-analytic coordinates has a strong literature (Laird et al., 2011; Ray et al., 2013; Smith et al., 2009 ), it has not previously been applied to VBM coordinates. This study (a) presents the meta-data structure, existing data volume, automated data-interpretation functions, and multi-purpose utility of BrainMap VBM; (b) reports 21 SCov networks computed by applying ICA to coordinates representing 30,218 diagnosed subjects (and 23,007 healthy control subjects) across 43 different diagnoses; (c) assesses an automated and semi-automated approach to detection and elimination of data-redundancy; and (d) applies hierarchal clustering analysis (HCA) to investigate the organizational architecture of SCov networks with respect to disease-and network-specificity.
| M E TH O DS
2.1 | BrainMap VBM meta-data structure and coding Basic criteria for BrainMap eligibility is whole-brain analysis (i.e., not region-of-interest methods), coordinate results reported in standardized space, and publication in an English-language journal. The BrainMap VBM hierarchical database design can be separated into Paper-level, Experiment-level, and Location-level tiers. Paper-level descriptors include-but are not limited to-basic citation information such as the journal, authors, keywords, and institution; an abstract summarizing the paper; each subject-groups' size, average age, gender ratio, specific inclusion-exclusion criteria, and relevant diagnosis (or diagnoses) according to the International Classification of Disease Codes managed by the World Health Organization per subject-group; any External Assessments that were used to evaluate subjects (e.g., Clinician
Administered PTSD Scale, Body-Mass Index, etc.); Session information including the number of scans and the time interval apart (e.g., pre-vs.
post-treatment, 3 months); the imaging modality used (e.g., 3T MRI) along with software packages, pre-processing protocol, and standardized space applied (i.e., MNI or Talairach); and a feedback field for any questions or comments for the BrainMap reviewing team.
In BrainMap, an Experiment is defined operationally by the production of a statistical parametric image (SPI) (Fox et al., 2005) . A Paper usually reports multiple Experiments. Each Experiment is generated based on criteria defining specific subsets of the subject-groups, Sessions, External Assessments (e.g., symptom score correlation), or statistical protocol-which Experiment-level taxonomy accounts for. Once a paper is coded via the Scribe software and submitted, it is verified for quality assurance by a taxonomy expert who has had extensive training. In addition, the user-interface that is implemented to code papers, Scribe, is regularly evaluated and updated to meet the needs of a bur- 
| Independent component analysis
To investigate transdiagnostic SCov, two filters were applied to the BrainMap VBM database in preparation for ICA; only (a) "Grey Matter"
Contrast and (b) "Disease" Context experiments were included (Figure 2 ).
These criteria encompassed most of the VBM database ( Table 1 ). The established method of Independent Component Analysis in BrainMap meta-data is shown in the Experiment ICA, (Figure 3a ) (Laird et al., 2011; Ray et al., 2013; Smith et al., 2009) . Peak coordinates in the VBM BrainMap database were smoothed using a Gaussian distribution (FWHM 5 12 mm) for "Modeled Activation" (MA) images with 2 3 2 3 2-mm resolution. ICA was then applied to the 2-D (vectorized voxel values 3 Experiment-ID) dataset using MELODIC (multivariate exploratory linear optimized decomposition into independent components; Beckmann, DeLuca, Devlin, & Smith, 2005) in FSL (FMRIB Software Library; Smith et al., 2004; Woolrich et al., 2009 ). Due to the ICA algorithm optimizing for non-Gaussianity in the spatial domain, the temporal domain remains unconstraint (Comon, 1994) . Therefore, MA images (which correspond to pseudo time-points in the present analysis) can be arbitrarily ordered.
In the current literature of ICA in T1-weighted data, the dimensionality has ranged considerably across studies. Values chosen include 7 (Eckert, 2010) , 9 (Hafkemeijer et al., 2014; Xu et al., 2009 ), 10 (Coppen et al., 2016 , and 75 (Segall et al., 2012) . We selected a dimensionality of 20.
Error and artifact naturally occur in massive meta-analytic datasets like BrainMap, and can stem from experiment mischaracterization, incorrect coordinate documentation, or-of which we address herewithin-group effects. Within-group effects (i.e., "data-redundancy", terms we use here interchangeably) impact the results of ALE and other CBMA methods when groups of subjects with multiple experiments (in a single paper) influence results more than subject groups with only one experiment (Turkeltaub et al., 2011) expedient solution from a programming perspective. However, collapsing the dataset this way reduced our data volume/statistical power and in some cases combined multiple biologically distinct statistical contrasts. We therefore investigated a separate strategy, the Experimentfiltered ICA (Figure 3c ). This required the removal of experiments that were data-redundant within a paper. To identify these outlier papers, we queried the database for papers that reported the same x-y-z coor- 
| Region-to-disease association
Two reverse inference methods were employed to measure the association, that is, weighting, of a given ROI or z-score image to distinct ICD-10 Diagnoses, that is, P (Diagnosis | Region). The regional analysis method ( Figure 3d ), extended from a region-to-function study by Lancaster et al. (2012), extracts coordinates for every ICD-10 Diagnosis separately; the fraction of coordinates falling within the specified ROI was computed and compared with the fraction expected if coordinates of the diagnosis were not clustered, that is, uniformly distributed across the brain. A significant disease association was determined if this discrepancy was large enough, producing a z-score �3.0 when corrected for multiple comparisons. Z-score calculation is provided below:
where observed probability (fraction of foci in ROI/outside of ROI) is p 0 , expected probability (fraction ROI/whole-brain volume) is p e , and number of total foci (i.e., across the whole-brain) per distinct ICD-10 is N b .
In a separate reverse inference method using spatial correlation 
| Hierarchal clustering analysis
Hierarchal clustering analysis (HCA) was performed on the (21 3 43) data matrix of network-disease loadings to identify clusters of components based on similar disease loading and, conversely, clusters of diseases according to their component loading. R Studio (www.r-project.
org) was used for heatmap visualization and HCA analysis using the package gplots (v3.0.1). Pearson's correlation (1 2 r) was used to calculate the "distance" metric. With the distance matrix, we employed an "average linkage" algorithm that calculated the average distance between elements of each cluster. A similar method was used by Laird et al. (2011) in their analyses of functional BrainMap ICA components. To identify an appropriate number of clusters (k) for HCA in both diseases and components, two separate statistical tests were applied to measure the "distinctness" of cluster groupings for every possible cluster size. These included the silhouette length (Rousseeuw, 1987) and the gap statistic (Tibshirani, Walther, & Hastie, 2001 ). An in-depth discussion of both methodologies can be found by Charrad, Ghazzali, Boiteau, and Niknafs (2014) .
| Age-related ALE
To better interpret the ICA components and their association with age, we utilized the full scope of BrainMap VBM beyond "Disease" Context.
The database was queried for experiments in the "Age" Context. We further excluded positive associations (i.e., hypertrophy) and multiple experiments from the same sample of subjects. The final analysis included 43 experiments representing 3,684 healthy and diseased subjects. Significant clusters in the ALE were identified using a clusterlevel family-wise error (cFWE) p 5 .05, and a cluster-forming p 5 .001.
Additionally, the unthresholded ALE image was spatially compared to the VBM ICA components. A spatial correlation was deemed significant according to the methodology explained by Smith et al. (2009) .
| Data and software sharing
All coordinate data used in this meta-analysis were accessed through the BrainMap VBM database. 
| Region-to-disease analyses
A disease-component heatmap is shown in Figure 5 ; average spatial cross correlation was employed per network to extract disease loadings. Figure 5 includes 43 ICD-10 diagnoses across 21 VBM-ICA components for a total of 903 weights (artifact components-as described in the preceding paragraph-were not included). Figure 5 excludes network weights from ICD-10 diagnoses with a small sample size (<10 experiments). The regional analysis and average spatial correlation region-to-disease methods (Figure 3d ,e) showed a significant association in a linear regression (Supporting Information, Figure 2 ).
| HCA disease and component clusters
Psychiatric diseases (ICD-10 F codes) were clearly separated from neurological disorders (ICD-10 G codes) after applying HCA, as is evident in the middle portion of Figure 5b . In the HCA analysis, total cluster numbers were specified at k 5 9 for components (each color corresponds to a cluster on the x-axis in Figure 5 ) and k 5 11 for diagnoses The other 10 components-that did not show strong within-cluster similarity-are anatomically summarized in Table 2 , and their networkdisease weights are presented in Figure 5 . 
| Age-related ALE

| D ISCUSSION
BrainMap has been extended to include voxel-based morphometry (VBM) studies in a separate sector, titled: BrainMap VBM. To date, BrainMap VBM contains coordinates from >3,000 experiments with detailed meta-data descriptors. The database is a community resource and can be utilized with a variety of univariate (e.g., ALE) and multivariate (e.g., MACM) meta-analytic approaches. As an illustrative use-case application,
we report an independent components analysis (ICA) on BrainMap VBM en masse to extract transdiagnostic, inter-experiment SCov components.
At the time of analysis, BrainMap VBM represented over 53,000 subjects across 43 ICD-10 diagnostic categories as well as healthy controls.
We demonstrate that automated and semi-automated data-cleaning approaches appropriately prepared BrainMap VBM for ICA by reducing data-redundancy effects. In addition, with 43 ICD-10 disease loadings calculated from 21 networks, hierarchical clustering (HCA) was performed to investigate the brain's structural architecture across disease.
| BrainMap VBM coding & region-to-disease inference tools
The BrainMap meta-data coding scheme is a descriptive system using mostly structured keywords to capture experimental methods and a graph theory analysis of diffusion tensor imaging (DTI) data of healthy subjects. They found that disease lesions most frequently target "hub"
| Data redundancy
regions, that is, grey matter nodes with the highest number of fiber tract connections, which included the posterior cingulate.
| Structural covariance in disease
The transdiagnostic SCov networks reported here reflect other disease-related SCov networks published. In an ICA of T1-weighted images of schizophrenia patients and controls combined, Xu et al. The transneuronal spread mechanism begins in an epicenter, often a hub (i.e., the hippocampus, insula, etc.), where alterations spread along axonal pathways in a "prion-like" manner (Ahmed et al., 2016; Zhou, Gennatas, Kramer, Miller, & Seeley, 2012) . (b) The nodal stress mechanism suggests that brain hubs are selectively susceptible to damage from oxidative stress and endothelial damage leading to impairments, such as a leaky blood brain barrier (Crossley et al., 2014) . ( HCA orders x-and y-axes by similarity between components according to disease weighting, and diseases according to component weighting. The labels "F" and "G" represent psychiatric and neurological ICD-10 disease codes, respectively, which were clustered by the HCA analysis. Clustering was chosen at k 5 9 and k 5 11 for components and diseases, respectively Anatomical clusters (z > 4) were identified in Mango using the "Find Overlay Cluster" tool. The Talairach 
| Structural covariance in healthy aging
Healthy, aging subjects have also been studied using structural ICA. Component M showed the highest spatial correlation to the ageassociated ALE (r 5 .28), and included brain regions involved in primary sensorimotor function (BA 2/3/4) and cognitive control (BA 9). Motor deficits in aging adults include coordination difficulty, slowing of movement, and difficulties with balance and gait (Seidler et al., 2010) . These results suggest that certain neurodegenerative diseases cause network morphology changes that converge with structural networks that strongly atrophy with age. Hafkemeijer et al. (2014) also reported that age was not significantly associated with gray matter volume in an inferior temporal and three cerebellar networks. These networks matched to Components I and Q respectively, and did not show significant ageassociation in this analysis.
While ICA included 17 VBM experiments measuring age effects in diseased populations, we did not find this small sample (0.8% of 2,002 experiments) contributed to the age-related atrophy convergence observed across multiple SCov components; those experiments did not show meaningful spatial coherence, that is, zero significant clusters in an ALE analysis (cFWE p 5 .05; cluster-forming p 5 .001).
| L I M I TA TI ONS
The experiments in the BrainMap VBM database varied considerably across the 43 ICD-10 diagnoses analyzed (Supporting Information, Figure 4) . The total number of experiments per disease ranged from 10 to 245 (median: 20) . Every experiment was included in the ICA analysis to incorporate as much data as possible for the data-mining experiment.
This limitation was explored with a regression analysis of each weight (in Figure 3) vs. experiment-count per disease, and a significant (p 5 .03), but small association was found (slope: 5.375 3 10 25 /experiment). This suggested that diseases with many experiments in the database (e.g., schizophrenia) indeed had more influence than diseases with less experiments (e.g., temporal sclerosis), but only a small effect was observed. As BrainMap VBM gains more traffic, we expect a more representative, and diagnostically homogenous sample of the current liter-
ature. An alternative CBMA database, Neurosynth (www.neurosynth.
org), employs a fully automated coordinate-/text-mining approach to populate their database (Yarkoni, Poldrack, Nichols, Van Essen, & Wager, 2011) . While this feature allows a quick, massive conglomeration of coordinates, it does not segregate different modalities (e.g., fMRI and VBM) and can conflate diametrically opposed meta-data categories (e.g., "saccades" and anti-"saccades"). BrainMap, however, relies on quality review by a managing team for each submission.
One limitation of the present analysis is more fundamental to the CBMA approach, which does not account subsignificant results. Alternatively, Neurovault (www.neurovault.org) stores 3-D unthresholded statistical parametric images (SPI) from each study rather than | 15 significant x-y-z coordinates; this methodology is defined as imagebased meta-analysis (IBMA) (Gorgolewski et al., 2015) . While IBMA incorporates data that can prove significant in aggregation, one persistent and fundamental drawback is the sparsity of SPIs shared. Significant, standardized x-y-z coordinates are reliably reported.
In this analysis, we did not explore the effect of ICA dimensionality. Instead, we chose d 5 20 because it is familiar to many readers ). The primary purpose of this analysis was to display the massive, transdiagnostic nature of this resource, and draw initial inferences. Future work can investigate varying dimensionality, as was done by Ray et al. (2013) in the functional sector.
| C ONC LUSI ON
BrainMap VBM is a new, accruing CBMA resource for structural neuroimaging, and can be utilized with univariate methodologies including ALE (via GingerALE software), MKDA, and SDM for convergence analyses to quantitatively summarize the VBM literature. In addition, the entire database can be leveraged en masse with more complex multivariate methodologies. As a use-case scenario, we extract transdiagnostic, inter-experiment SCov networks which exhaustively illustrate the content of the database and its region-to-disease capability. Some networks reflect previously published inter-subject ICA SCov components from Alzheimer's, schizophrenia, aphasia, and Huntington's disease, as well in healthy, aging subjects (Coppen et al., 2016; Hafkemeijer et al., 2014; Seeley et al., 2009; Xu et al., 2009) . A component showing nonspecific disease weighting compliments previous work suggesting a shared endophenotype across psychiatric diseases (Goodkind et al., 2015) . The significantly weaker psychiatric network loading reiterates the need to better distinguish mental disorders according to neurobiological principles (Insel et al., 2010) . We hope this resource facilitates reproducibility in the field of structural neuroimaging.
